In addition to its involvement in inflammatory cell trafficking during colitis and IBD, VCAM-1 has recently been implicated to play a critical role in tumour development in CRC via similar cell migration–based mechanisms [51]. This evidence concerns the gene VCAM1 and inflammatory bowel disease.